Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

REFG
Sort by: Date|Relevance

Forging a New Path into the Medical Cannabis Space

Although 2019 was in many ways ‘The Year that the Cannabis Sector Would Like to Forget’, there are many pioneering ways that a company can take to generate revenue in the still-emerging medical cannabis and CBD markets. One such company has been advancing st...

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...

Software For Safe Medical Cannabis Access

Alternate Health’s integrated health services features clinical laboratories and CanaPass - online patient management software for safe access to medical cannabis. Currently generating revenue, Alternate Health plans to reinvest profit...

Aurora Cannabis, EXMceuticals, Tilray - Cannabis development in Portugal

From the street to the clinic. Cannabis had the image of an illegal street drug in most rich countries since the prohibition in the USA in the 1930s. Although cannabis has been used as a medicinal plant for more than 1,000 years, the past decades have been marked by other phar...

Reigniting the Cannabis Oral Delivery System Marketplace

This podcast is part of our Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public marketplace. Stockhouse Media's Dave Jackson was recently joined live with Bra...

This Cannabis Co. Earned a 100% Revenue Increase Over 3 Consecutive Quarters

(Click image to play video) Avicanna Inc. ( TSX: AVCN , OTCQX: AVCNF , Forum ) is a diversified and vertically integrated Canadian biopharmaceutical Company that is focused on the research, development, and commercialization of plant-derived cannabinoid-based products...

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...

This Canadian Biopharmaceutical Co. is a Pioneer of the Medical Cannabis Industry

An evidence-based, scientific approach is how Avicanna Inc. ( TSX.AVCN , OTC: AVCNF , Forum ) gains its competitive advantage in the medical cannabis sector. The Canadian biopharmaceutical company has spent over four years in research & development before creating its m...

Premier Health Group Adding Medical Cannabis Support Tool

This clinical decision support software integration is the first of its kind, according to the company. Canada-based Premier Health Group Inc. (PHGI:CSE; PHGRF:OTCQB; 6PH:FSE) , a company focused on "developing innovative approaches that combine human skill-based exper...

StockTalk Exclusive! Cannabis Industry Icon Steve DeAngelo

Steve DeAngelo chats with Cindy Broad for the Arcview 2020 Vision Series First Forum: Cannabis Investing for a New Decade. Listen to Steve's colourful commentary on everything from surviving the dip, to what's next for the industry, to his views on psychedelics......
1 2 3 4 5 6 7 8 9 10 ...